Skip to main content
Veterinary Medicines

Tenazym suspensija lietošanai iekšķīgi vai uz ādas suņiem un kaķiem

Authorised
  • Tetracycline hydrochloride
  • NEOMYCIN SULFATE
  • Prednisolone acetate
  • Chymotrypsin
  • Trypsin
  • Papain

Product identification

Medicine name:
Tenazym suspensija lietošanai iekšķīgi vai uz ādas suņiem un kaķiem
Active substance:
  • Tetracycline hydrochloride
  • NEOMYCIN SULFATE
  • Prednisolone acetate
  • Chymotrypsin
  • Trypsin
  • Papain
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use
  • Cutaneous use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    30.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • NEOMYCIN SULFATE
    22.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Prednisolone acetate
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Chymotrypsin
    120.00
    FIP
    /
    1.00
    millilitre(s)
  • Trypsin
    12.00
    FIP
    /
    1.00
    millilitre(s)
  • Papain
    1.50
    FIP
    /
    1.00
    millilitre(s)
Pharmaceutical form:
This information is not available for this product.
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
  • Cutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RV
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/99/1034
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 20/03/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 20/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 20/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."